Follow Us:
Saturday, January 22, 2022

Tushar Gore

Dr Tushar Gore’s focus area is pharmaceuticals. He studied at IIT-Bombay and the University of Minnesota, and has worked at McKinsey and Novo Nordisk. He is the former MD/CEO of Resonance Laboratories, a niche pharmaceuticals manufacturer.

An Expert Explains: Why vaccine efficacy is declining, and the implications of a third dose
Tue, Sep 28, 2021

Recent data suggest that the effectiveness of Covid-19 vaccines has been declining. A look at the possible reasons, and the implications of a third dose.

Why 30x undercount in Covid deaths is unlikely
Tue, Jul 27, 2021

Tushar Gore and Viral V Acharya write: High death undercounts are limited to short time spans when the capacity is overwhelmed. For eight districts that have been analysed, it is roughly between 3-9x.

An Expert Explains: The complexities of herd immunity
Fri, Apr 30, 2021

In several metros where serosurveys showed high immunity levels, Covid cases are still surging. What does that say about the concept of 'herd immunity'? Accounting for transmission involves several factors.

An Expert Explains: Four key things you must know about Covid-19 vaccines
Wed, Sep 16, 2020

What are the issues of safety and efficacy that you hear about? When will a vaccine be available? Is the vaccine being fast-tracked, and, therefore, unsafe? Can we trust the vaccine when it is approved?

An Expert Explains: Should you test for Covid-19 just to check?
Mon, Aug 03, 2020

Not advised, because the probability of being falsely identified as Covid-19-positive is quite high. When no test is 100% accurate, the key aspect to consider is disease prevalence in the population that is being tested